Display options
Share it on

Case Rep Oncol. 2014 May 08;7(2):297-300. doi: 10.1159/000362788. eCollection 2014 May.

Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations.

Case reports in oncology

Rodney Shackelford, Maressa Pollen, Moise Vora, Tamara T Jusion, James Cotelingam, Binu Nair

Affiliations

  1. Department of PathologyClinical Pathology Molecular Pathology Consultative Services, La., USA.
  2. Clinical Pathology Molecular Pathology Consultative Services, La., USA.
  3. Hematology/Oncology, LSU Health Shreveport, Shreveport, La., USA.

PMID: 24926260 PMCID: PMC4035678 DOI: 10.1159/000362788

Abstract

Cutaneous melanoma is an aggressive malignant tumor of melanocytes which accounts for 80% of skin cancer-related deaths. A number of driver mutations have been identified in melanoma, with the mutually exclusive BRAF V600E and NRAS Q61A mutations together accounting for roughly 70% of mutations. Simultaneous BRAF V600E and NRAS Q61A mutations in melanoma are rare, with evidence suggesting that up to 2.9% (2/69) of primary cutaneous melanomas carry both mutations. Here we describe a 42-year-old man with concurrent BRAF E586K and NRAS Q81K driver mutations. To our knowledge, this is the first description of these driver mutations occurring simultaneously in primary cutaneous melanoma.

Keywords: Concurrent BRAF E586K and NRAS Q81K mutations; Cutaneous melanoma; Skin cancer

References

  1. Oncogene. 2013 May 9;32(19):2373-9 - PubMed
  2. Nature. 2010 Dec 16;468(7326):973-7 - PubMed
  3. N Engl J Med. 2006 Jul 6;355(1):51-65 - PubMed
  4. Eur J Cell Biol. 2014 Jan-Feb;93(1-2):1-10 - PubMed
  5. Mod Pathol. 2006 Feb;19 Suppl 2:S34-40 - PubMed
  6. J Invest Dermatol. 2006 Jan;126(1):154-60 - PubMed
  7. Cell. 2004 Mar 19;116(6):855-67 - PubMed
  8. Nature. 2009 Sep 24;461(7263):542-5 - PubMed

Publication Types